“…Therefore, potential advantages of the TPCS remain questionable, and its use is still debated. (9)(10)(11) Several older, small, prospective studies that were nonrandomized, randomized, and retrospective Pietersen et al Abbreviations: A+S+, temporary portocaval shunt with initial arterial reperfusion; A+S−, no temporary portocaval shunt with initial arterial reperfusion; A−S+, temporary portocaval shunt with initial portal reperfusion; A−S−, no temporary portocaval shunt with initial portal reperfusion; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BAR, balance of risk; BMI, body mass index; CIT, cold ischemia time; DBD, donation after brain death; DCD, donation after circulatory death; DRM, donor-recipient model; ET-DRI, Eurotransplant donor risk index; FFP, fresh frozen plasma; GGT, gamma-glutamyltransferase; IAR, initial arterial reperfusion; INR, international normalized ratio; LT, liver transplantation; MELD, Model for End-Stage Liver Disease; NR, not reported; OLT, orthotopic liver transplantation; PTT, partial thromboplastin time; PV, portal Original article | 1691 investigated initial arterial reperfusion (IAR) (12)(13)(14)(15)(16)(17) and showed controversial results on outcomes after liver transplantation (LT). Thus, the ideal sequence of reperfusion is an issue that is still debated.…”